|
1
|
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
J Clin Oncol
|
2014
|
3.07
|
|
2
|
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
|
BMJ
|
2014
|
2.60
|
|
3
|
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.
|
Fam Cancer
|
2005
|
1.57
|
|
4
|
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.
|
Breast Cancer Res Treat
|
2015
|
1.37
|
|
5
|
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.
|
Cancer Genet Cytogenet
|
2006
|
1.25
|
|
6
|
Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.
|
Breast J
|
2007
|
1.02
|
|
7
|
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.98
|
|
8
|
Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.
|
Am J Gastroenterol
|
2011
|
0.97
|
|
9
|
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.
|
Lab Invest
|
2008
|
0.96
|
|
10
|
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
|
J Clin Oncol
|
2012
|
0.91
|
|
11
|
Can unknown predisposition in familial breast cancer be family-specific?
|
Breast J
|
2013
|
0.90
|
|
12
|
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.
|
Breast Cancer Res
|
2013
|
0.90
|
|
13
|
Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.
|
Breast J
|
2007
|
0.89
|
|
14
|
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.
|
Cancer
|
2007
|
0.85
|
|
15
|
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.
|
Fam Cancer
|
2010
|
0.82
|
|
16
|
Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
|
BMC Cancer
|
2014
|
0.82
|
|
17
|
Hereditary breast cancer: practical pursuit for clinical translation.
|
Ann Surg Oncol
|
2012
|
0.81
|
|
18
|
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
|
Fam Cancer
|
2013
|
0.78
|
|
19
|
Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers.
|
J Clin Oncol
|
2009
|
0.78
|
|
20
|
Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.
|
J Genet Couns
|
2013
|
0.77
|
|
21
|
Barrett's esophagus in the patients with familial adenomatous polyposis.
|
Fam Cancer
|
2014
|
0.77
|
|
22
|
Genome instability in blood cells of a BRCA1+ breast cancer family.
|
BMC Cancer
|
2014
|
0.76
|
|
23
|
Five families living with hereditary breast and ovarian cancer risk.
|
Clin J Oncol Nurs
|
2009
|
0.76
|
|
24
|
Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6.
|
Semin Oncol
|
2012
|
0.75
|